Whitehawk Therapeutics (WHWK) Divestments (2025)

Whitehawk Therapeutics (WHWK) reported Divestments of -$70000.0 for Q3 2025, down 100.07% quarter-over-quarter from $101.4 million in Q1 2025.

Whitehawk Therapeutics (WHWK) Divestments (2025) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 1 years of Divestments data on file, last reported at -$70000.0 in Q3 2025.

  • Divestments for Q3 2025 came in at -$70000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$70000.0 (down 100.07% YoY), and the FY2025 annual result was $101.3 million, changed N/A from the prior year.
  • Divestments eased to -$70000.0 in Q3 2025 per WHWK's latest filing, from $101.4 million in the prior quarter.
  • Over five years, Divestments peaked at $101.4 million in Q1 2025 and troughed at -$70000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Whitehawk Therapeutics 310.18 Mn 187.14 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -70,000.00
Mar 31, 2025 101.36 Mn